These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrest. Engelman RM; Auvil J; O'Donoghue MJ; Levitsky S J Thorac Cardiovasc Surg; 1978 Apr; 75(4):555-63. PubMed ID: 642549 [TBL] [Abstract][Full Text] [Related]
8. [The protective effect of magnesium-aspartate-procaine cardioplegia on the hypertrophied left ventricle of the mini-pig (author's transl)]. Seybold-Epting W; Fenchel G; Huth C; Hoffmeister HE; Heller W Thoraxchir Vask Chir; 1978 Jun; 26(3):205-8. PubMed ID: 150067 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and experimental evaluation of myocardial protection by magenesium-procaine solution (Kirsh solution) and cold HES perfusion]. Kato I; Kaihotsu N; Okada K; Fukuda T; Sugimoto T Nihon Kyobu Geka Gakkai Zasshi; 1978 Mar; 26(3):369-71. PubMed ID: 81251 [No Abstract] [Full Text] [Related]
10. Metabolism and structure of the magnesium aspartate-procaine-arrested ischaemic heart of rabbit and man. Döring V; Baumgarten HG; Bleese N; Kalmar P; Pokar H; Gercken G Basic Res Cardiol; 1976; 71(2):119-32. PubMed ID: 944573 [TBL] [Abstract][Full Text] [Related]
11. Effects of procaine-induced cardioplegia on myocardial ischemia, myocardial edema, and postarrest ventricular function. A comparison with potassium-induced cardioplegia and hypothermia. Bixler TJ; Gardner TJ; Flaherty JT; Goldman RA; Gott VL J Thorac Cardiovasc Surg; 1978 Jun; 75(6):886-93. PubMed ID: 661357 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural study comparing the efficacy of five different methods of intraoperative myocardial protection in the human heart. Schaper J; Scheld HH; Schmidt U; Hehrlein F J Thorac Cardiovasc Surg; 1986 Jul; 92(1):47-55. PubMed ID: 3088335 [TBL] [Abstract][Full Text] [Related]
13. [Effects of cardioplegic solutions on coronary and myocardial ultrastructure. Preliminary note]. Macchiarelli G; Chiavarelli R; Macchiarelli A; Chiavarelli M; Toscano M; Carpi A; Marino B G Ital Cardiol; 1983 Aug; 13(8):106-12. PubMed ID: 6418607 [TBL] [Abstract][Full Text] [Related]
14. [Methods of myocardium defense in radical correction of Ebstein anomaly]. Lazorishinets VV; Loskutov OA Klin Khir; 2001 Sep; (9):9-12. PubMed ID: 11785414 [TBL] [Abstract][Full Text] [Related]
16. [Animal experiment evaluation of myocardial protection with a magnesium-asparaginate-procaine solution]. Walpoth B; Fornaro M; von Gossler W; Turina M Chir Forum Exp Klin Forsch; 1978; (1978):99-102. PubMed ID: 752612 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural and biochemical changes of human papillary heart muscle during different methods of induced cardiac arrest. Fenchel G; Seybold-Epting W; Seiter H; Huth C; Hoffmeister HE; Schlote W; Heller W Thorac Cardiovasc Surg; 1979 Aug; 27(4):241-4. PubMed ID: 494222 [TBL] [Abstract][Full Text] [Related]
19. [Myocardial metabolic status in various methods of inducing a reversible heart arrest]. Isselhard W; Schorn B; Uekermann U; Hügel W Chir Forum Exp Klin Forsch; 1979; ():29-32. PubMed ID: 456143 [TBL] [Abstract][Full Text] [Related]